Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging. - Wikidata - awgldk - TriplyDB

Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging.

Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging.

http://www.wikidata.org/entity/Q39780518

about

Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity Lanthanide probes for bioresponsive imaging Gadolinium-based nanoparticles for theranostic MRI-radiosensitization Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine Nanodiscs as a Modular Platform for Multimodal MR-Optical Imaging Multimodality and nanoparticles in medical imaging Gold nanoparticles delivery in mammalian live cells: a critical review Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality.Magnetic colloidal supraparticles: design, fabrication and biomedical applications.Gd(III)-labeled peptide nanofibers for reporting on biomaterial localization in vivo High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation.Poly(acrylic acid) Bridged Gadolinium Metal-Organic Framework-Gold Nanoparticle Composites as Contrast Agents for Computed Tomography and Magnetic Resonance Bimodal Imaging.Gadolinium containing telechelic PEG-polymers end-capped by di-phenylalanine motives as potential supramolecular MRI contrast agents.Cyclodextrin-based bimodal fluorescence/MRI contrast agents: an efficient approach to cellular imaging.Cell labeling via membrane-anchored lipophilic MR contrast agents Design and development of quantum dots and other nanoparticles based cellular imaging probe.Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles.Gd(III) functionalized gold nanorods for multimodal imaging applications.Probing the Chemical Stability of Mixed Ferrites: Implications for MR Contrast Agent Design Strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates.Improving T₁ and T₂ magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes.Functionalisation of lanthanide complexes via microwave-enhanced Cu(I)-catalysed azide-alkyne cycloaddition.Analytical methods for characterizing magnetic resonance probes.Generic delivery of payload of nanoparticles intracellularly via hybrid polymer capsules for bioimaging applications.Graphene oxide enhances cellular delivery of hydrophilic small molecules by co-incubation.A cell-permeable gadolinium contrast agent for magnetic resonance imaging of copper in a Menkes disease model Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release.High-performance nanostructured MR contrast probes.Mechanisms of Gadographene-Mediated Proton Spin Relaxation.Synthesis and characterization of a porphyrazine-Gd(III) MRI contrast agent and in vivo imaging of a breast cancer xenograft model.Tunable loading of oligonucleotides with secondary structure on gold nanoparticles through a pH-driven method.Investigation of Förster resonance energy transfer (FRET) and competition of fluorescent dyes on DNA microparticles Silica microparticles as a solid support for gadolinium phosphonate magnetic resonance imaging contrast agents.Targeted delivery of gold nanoparticle contrast agents for reporting gene detection by magnetic resonance imaging DNA-gadolinium-gold nanoparticles for in vivo T1 MR imaging of transplanted human neural stem cells.Toward personalized cancer nanomedicine - past, present, and future.Conjugation to Biocompatible Dendrimers Increases Lanthanide T2 Relaxivity of Hydroxypyridinone (HOPO) Complexes for Magnetic Resonance Imaging (MRI)Synthesis, Characterization, and in vitro Testing of a Bacteria-Targeted MR Contrast Agent.

P2860

Q24594049-5BC4CEC0-5C61-4801-BF8B-C17113EAB3D0 Q27000361-FA318642-6928-4672-8067-4443AD6A41DB Q27027308-A0CC9F8C-074A-447A-B4DA-F054DE27A35A Q28391849-0BB172AC-7852-4458-B05F-0E2B4B636391 Q28397423-D06949B5-7C13-485E-99D3-1B8AE0830696 Q30407070-8217E3EE-CF92-41B3-891E-C11B2A41DF5A Q30472806-4C585BDC-B099-4FF2-86AF-7919A6334B82 Q30577878-13F1BEFB-90E3-4503-B92E-75242396CCA4 Q30585395-45C76718-07DE-4416-87E0-0E79D4979217 Q30664539-FA0D3BE5-11EB-4A45-ABE9-343245767E96 Q30831724-FC8EC7BB-AA64-4406-91FC-F21FABB8F5BC Q30901328-1E79BFDD-0127-48D4-8E43-55C970256369 Q30978842-569AA682-5DCE-4104-B26A-90B2D20942F2 Q31143260-A518F38F-7100-40B3-9019-E516D499911E Q33617992-9FE3FC2F-1B90-44E3-8D65-EF61709AF2CF Q33662424-563F5AF8-4CB0-4A70-AB9C-E11045B72464 Q33744101-DD91EA18-9E24-4E4A-A527-E2BB75B8EC24 Q33744219-469DFFCF-8B35-411D-9980-5A19CA3FCBC5 Q33839558-E97DB45D-2B6F-4FDB-8C69-E20C1A3781EB Q33908288-A73FEFA6-BEAC-4163-8E0F-B950CE1D0269 Q33980411-63366F32-29D9-46BA-A909-A4CCAB4C593F Q34161701-68DD91A5-6D3D-4C98-A148-539B27DC62B0 Q34278539-4C086DCA-BCDE-4F2A-AE67-AB14CFD0E751 Q34280357-044DDFBC-9F70-4079-BBFF-573E8EBBFD87 Q34287344-0CD60224-BCD5-4E61-A181-FEA99BE31E50 Q34419918-0C002435-C6BD-4E61-ADA3-4E4BCAE03E4D Q34568075-E53200EA-1AFF-4D4C-A9CA-7F1FC0092E6D Q34714550-F3C3E4CF-0E76-416C-958A-2358337EAE28 Q34988879-51F2876E-92A1-4602-8144-AD83343C7952 Q35031050-1930819F-285E-4D33-9688-1F713AEB940C Q35057923-96EA76EB-6591-4E5F-9A13-BBB6E016D4F3 Q35082611-EFBEAB00-9C38-4689-A4E4-EC31D09D7CC2 Q35566176-6D0802BF-92A8-40C5-B617-047C92699630 Q35585550-B63711BA-F6E7-4F6C-9A4E-03BB0FE0A045 Q36112041-02CD167D-99BA-4651-9E11-43C6B05E9A70 Q36372692-A589140F-14AA-495D-BA86-79CECAD4ED28 Q36385087-3EC108E2-A695-4868-9BB4-B3036DAD314C Q36472802-CDA702AB-45A4-42FA-9979-694D9A5CFCE2 Q36714422-9B3EE4A2-D7AF-4445-98AD-D3B46F598F5B Q36790782-05704CDF-A7C0-4037-A15B-71CA06293548

P2860

Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging.

http://www.wikidata.org/entity/Q39780518

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging.

@en

Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging.

@nl

type

label

Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging.

@en

Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging.

@nl

prefLabel

Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging.

@en

Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging.

@nl

P1433

Q39780518-01741613-E025-42E1-9312-810F83DB4D49

P1476

Q39780518-4087FF12-112C-4832-9F9A-BC78862979EF

P2093

Q39780518-786C3786-D31F-4E17-976C-E2DA35A29BA8

Q39780518-8183F6C2-0F86-45A6-A956-9716D4EB6DF9

Q39780518-88DA3147-0FC6-4170-B6C9-60CA5AE03D41

Q39780518-89B449AA-3190-46C9-AAE7-914A9619586E

Q39780518-F9FF1876-1A74-4A73-81B2-FA1E11F9DC22

P2860

Q39780518-01AE0D62-8D1D-4301-B62D-2DFAADF85D3D

Q39780518-0280D1A6-92F7-4CD7-9672-8D7FB3FD4C6E

Q39780518-11BD05A3-90A4-48DF-844A-2E2B27587387

Q39780518-11E0107C-756B-451C-A568-CBB0282C1823

Q39780518-1688D89A-9B2D-4644-A0F2-DBD585E9671D

Q39780518-175C8EB0-C602-4F71-BB52-432EE8394394

Q39780518-2F25A1B0-3136-4EC8-A55A-602120C7C8FF

Q39780518-2F987900-5C64-462E-8B7D-14C3B65762F2

Q39780518-3B2017F7-39B2-46B0-9FDC-9FABCFA95C25

Q39780518-5831C0D5-4C72-430F-B845-812383150BA3

P304

Q39780518-40CF0A8D-5927-4AF9-94DD-479C63659A39

P31

Q39780518-5C425752-D48F-4B0B-B184-F9C023C3E2D3

P356

Q39780518-59BDA0D2-6ACD-44B7-B91C-66546CF27024

P407

Q39780518-E7912B2C-6E8F-4119-990F-F9E1CCD716AF

P433

Q39780518-3EC0F6D1-DC0E-4A01-B825-18792AAEF220

P478

Q39780518-49D993CF-5096-4AA2-B2CF-AA8894DCC2F9

P50

Q39780518-1CF2D301-45B8-4A40-9DA1-8B45103012DA

P577

Q39780518-1F2291BF-34B3-4068-87FF-EB2B16355C07

P5875

Q39780518-0F8E710A-0E7B-4D38-AC16-EB943020C176

P698

Q39780518-797D7FC3-C300-4728-A7C1-E62DB6C52E7A

P921

Q39780518-9AB33853-7989-406F-B8CE-351C1245E193

P932

Q39780518-4767BD37-20B4-4409-950F-45590728C344

P356

P1433

Angewandte Chemie International Edition

P1476

Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging.

@en

P2093

Keith W MacRenaris

http://www.w3.org/2001/XMLSchema#string

Thomas J Meade

http://www.w3.org/2001/XMLSchema#string

Xiaoyang Xu

http://www.w3.org/2001/XMLSchema#string

Xue-Qing Zhang

http://www.w3.org/2001/XMLSchema#string

Ying Song

http://www.w3.org/2001/XMLSchema#string

P2860

A DNA-based method for rationally assembling nanoparticles into macroscopic materials

The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

Cellular delivery of MRI contrast agents.

A gadolinium chelate for detection of beta-glucuronidase: a self-immolative approach.

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

Potentiometric and relaxometric properties of a gadolinium-based MRI contrast agent for sensing tissue pH

The synthesis and in vitro testing of a zinc-activated MRI contrast agent.

Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.

Bioresponsive, cell-penetrating, and multimeric MR contrast agents.

Gold nanoparticles functionalized with gadolinium chelates as high-relaxivity MRI contrast agents.

P304

9143-9147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANIE.200904666

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38060787

http://www.w3.org/2001/XMLSchema#string

P698

19882611

http://www.w3.org/2001/XMLSchema#string

P921

P932

2917899

http://www.w3.org/2001/XMLSchema#string